Longitudinal profiling reveals a persistent intestinal dysbiosis triggered by conventional anti-tuberculosis therapy/Experiment 14/Signature 2

EditHistoryDelete

Mark reviewed

Your review change was submitted

Needs review

Curated date: 2024/11/09

Curator: KateRasheed

Revision editor(s): KateRasheed

Source: Fig. 3C

Description: Differentially abundant taxa between the naïve and TB + HRZ groups from day 1(W4) to the termination of therapy(W20).

Abundance in Group 1: decreased abundance in TB + HRZ groups (W4-W20 time points)

NCBI	Quality Control	Links
Dorea
Syntrophococcus
Acetivibrio
Pseudobutyrivibrio
Robinsoniella
Alkaliphilus
Stomatobaculum
Tyzzerella
Ruminococcus
Butyricicoccus
Acidaminobacter
Acetanaerobacterium
Sporobacter
Roseburia
Peptococcus
Romboutsia
Clostridium
Dysgonomonas
Turicibacter
Bacteroides

Revision editor(s): KateRasheed